Synlett 2009(13): 2154-2156  
DOI: 10.1055/s-0029-1217544
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of Functionalized 2′,4-Diarylbenzophenones Based on Site-Selective Suzuki Cross-Coupling Reactions

Muhammad Nawaza, Muhammad Adeela, Muhammad Farooq Ibada, Peter Langer*a,b
a Institut für Chemie, Universität Rostock, Albert Einstein Str. 3a, 18059 Rostock, Germany
b Leibniz-Institut für Katalyse an der Universität Rostock e.V., Albert Einstein Str. 29a, 18059 Rostock, Germany
Fax: +49(381)4986412; e-Mail: peter.langer@uni-rostock.de;
Further Information

Publication History

Received 6 April 2009
Publication Date:
10 July 2009 (online)

Abstract

The palladium(0)-catalyzed Suzuki cross-coupling reaction of the bis(triflates) of 2′,4-dihydroxybenzophenones afforded 2′,4-diarylbenzophenones. The reactions proceeded with very good site selectivity. The first attack occurred at carbon atom C-4.

    References and Notes

  • 1 De Souza AO. Santos RR. Melo PS. Alderete JB. De Conti R. Haun M. Sato DN. Duran N. Pharmazie  2001,  56:  871 
  • 2 De Souza AO. Alderete JB. Schmidt F. Sato DN. Duran N. Arzneim. Forsch.  1999,  49:  1025 
  • 3 Kumar S. Seth M. Bhaduri AP. Agnihotri A. Srivastava AK. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.  1984,  23:  154 
  • 4 Batt DG. Goodman R. Jones DG. Kerr JS. Mantegna LR. J. Med. Chem.  1993,  36:  1434 
  • 5 Holt DA. Yamashita DS. Konialian-Beck AL. Luengo JI. Abell AD. J. Med. Chem.  1995,  38:  13 
  • 6 Dannhardt G. Fiebich BL. Schweppenhaeuser J. Eur. J. Med. Chem. Chim. Ther.  2002,  37:  147 
  • 7 Lenhart A. Reinert DJ. Aebi JD. Dehmlow H. Morand OH. Schulz GE. J. Med. Chem.  2003,  46:  2083 
  • 8 Guarnieri A. Burnelli S. Varoli L. Busacchi I. Barbaro AM. Arch. Pharm. (Weinheim Ger.)  1981,  314:  703 
  • 9 Aburaki S. Okuyama S. Hoshi H. Kamachi H. Nishio M. J. Antibiot.  1993,  46:  1447 
  • 10 Pettit GR. Toki B. Herald DL. Verdier-Pinard P. Boyd MR. Hamel E. Pettit RK. J. Med. Chem.  1998,  41:  1688 
  • 11a Liou J.-P. Chang J.-Y. Chang C.-W. Chang C.-Y. Mahindroo N. Kuo F.-M. Hsieh H.-P. J. Med. Chem.  2004,  47:  2897 
  • 11b Liou J.-P. Chang C.-W. Song JS. Yang YS. Yeh CF. Tseng HY. Lo YK. Chang C.-L. Chang C.-M. Hsieh H.-P. J. Med. Chem.  2002,  45:  2556 
  • 12 Appel B. Rotzoll S. Kranich R. Reinke H. Langer P. Eur. J. Org. Chem.  2006,  3638 
  • 13 Cai X. Sakamoto M. Fujitsuka M. Majima T. Chem. Eur. J.  2005,  11:  6471 ; and references cited therein
  • 14 Langhals H. Fuchs K. Chem. Unserer Zeit  2004,  38:  98 ; and references cited therein
  • 15 Buchta E. Egger H. Chem. Ber.  1957,  90:  2760 
  • 16 For the SmI2-mediated reaction of benzaldehydes with benzyl halides and subsequent oxidation, see: Shiue J.-S. Lin M.-H. Fang J.-M. J. Org. Chem.  1997,  62:  4643 
  • 17 For a review of site-selective palladium(0)-catalyzed cross-coupling reactions, see: Schröter S. Stock C. Bach T. Tetrahedron  2005,  61:  2245 
18

Typical Procedure for the Synthesis of 6a-j:
A 1,4-dioxane solution (5 mL/mmol of 4) of 5a-j, K3PO4, Pd(PPh3)4 and 4 was stirred at 110 ˚C for 4 h. After cooling to 20 ˚C, a sat. aq solution of NH4Cl was added, the organic and the aqueous layer were separated and the latter was extracted with CH2Cl2. The combined organic layers were dried (Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was purified by column chromatography.

19

Methyl 4′-Methyl-4-(4′-methylbiphenylcarbonyl)-biphenyl-2-carboxylate (6a): Starting with 4 (220 mg, 0.4 mmol), K3PO4 (261 mg, 1.2 mmol), Pd(PPh3)4 (3 mol%), p-tolylboronic acid (144 mg, 1.1 mmol) and 1,4-dioxane (2 mL), 6a was isolated as a highly viscous oil (200 mg, 84%). ¹H NMR (300 MHz, CDCl3): δ = 2.17 (s, 3 H, CH3), 2.30 (s, 3 H, CH3), 3.56 (s, 3 H, OCH3), 6.95 (d, 2 H, J = 8.0 Hz, ArH), 7.04-7.21 (m, 6 H, ArH), 7.35-7.53 (m, 5 H, ArH), 7.70 (dd, 1 H, J = 1.9, 8.0 Hz, ArH), 7.98 (d, 1 H, J = 1.9 Hz, ArH). ¹³C NMR (62.89 MHz, CDCl3): δ = 21.0 (CH3), 21.2 (CH3), 52.1 (OCH3), 126.9 (4 × C, CH), 127.9, 128.8, 128.9 (CH), 129.0 (4 × C, CH), 130.2, 130.6, 131.4, 132.1 (CH), 135.8 (2 × C), 137.1 (C), 137.2 (2 × C), 137.7, 138.3, 141.3, 146.3, 168.4 (C), 197.4 (C=O). IR (KBr): 3080, 3057, 3025 (w), 1724, 1659 (s), 1613 (w), 1595 (m), 1574, 1518 (w), 1438, 1310, 1277 (m), 1231 (s), 1152, 1082, 972 (m), 819, 704 (s), 536 (m) cm. GC-MS (EI, 70 eV): m/z (%) = 420 (100) [M+], 405 (21), 373 (09), 359 (23), 332 (07), 253 (26), 210 (07), 195 (40), 165 (39), 152 (25). HRMS (EI): m/z [M+] calcd for C29H24O3: 420.17200; found: 420.17153.

20

Methyl 2′-Bromo-4-[2-(trifluoromethylsulfonyloxy)-benzoyl]biphenyl-2-carboxylate (7d): Starting with 4 (150 mg, 0.3 mmol), K3PO4 (171 mg, 0.8 mmol), Pd(PPh3)4 (3 mol%), 2-bromophenylboronic acid (65 mg, 0.3 mmol) and 1,4-dioxane (2 mL), 7d was isolated as a highly viscous oil (120 mg, 78%). ¹H NMR (300 MHz, CDCl3): δ = 3.58 (s, 3 H, OCH3), 7.13-7.17 (m, 2 H, ArH), 7.28-7.39 (m, 3 H, ArH), 7.43-7.48 (m, 1 H, ArH), 7.54-7.62 (m, 3 H, ArH), 7.94 (dd, 1 H, J = 2.1, 8.0 Hz, ArH), 8.36 (d, 1 H, J = 2.1 Hz, ArH). ¹³C NMR (75.46 MHz, CDCl3): δ = 52.3 (OCH3), 122.7, 127.1, 128.3, 129.2, 129.7, 129.8, 131.3, 131.8, 132.3, 132.9, 133.2 (CH), 134.6, 134.9, 135.0, 136.0, 141.5, 146.7, 146.8, 147.2, 166.2 (C), 191.4 (C=O). ¹9F NMR (282 MHz, CDCl3): δ = -73.29 (CF). IR (KBr): 3053, 2953, 2923 (w), 1728, 1672 (s), 1567 (m), 1482 (w), 1309, 1294 (m), 1241, 1203 (s), 1168 (m), 1087 (s), 948 (m), 887, 769, 592 (s) cm. MS (EI, 70 eV): m/z (%) = 544 (100) [M+], 331 (12), 301 (48), 271 (24), 242 (75), 215 (7), 183 (5), 151 (11), 69 (15). HRMS (EI): m/z [M+] calcd for C22H14BrF3O6S: 544.17200; found: 544.171525.